Системные гипертензии (Oct 2020)

Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19

  • Irina E. Chazova,
  • Natalia V. Blinova,
  • Vera A. Nevzorova,
  • Juliya V. Zhernakova,
  • Mikhail P. Savenkov,
  • Elena V. Oshchepkova,
  • Olga D. Ostroumova,
  • Oksana A. Kisliak,
  • Sergey A. Boytsov

DOI
https://doi.org/10.26442/2075082X.2020.3.200362
Journal volume & issue
Vol. 17, no. 3
pp. 35 – 41

Abstract

Read online

The novel coronavirus infection (COVID-19) caused by the b-coronavirus SARS-CoV-2, and leads to acute respiratory distress-syndrome, has affected more than nineteen million people worldwide, resulting in 0.7 million deaths as of August 2020. The fact that the virus uses angiotensin-converting enzyme 2 as a receptor for entering the target cell, and the high prevalence of hypertension and other cardiovascular diseases among patients with COVID-19, have caused serious discussions on the management of such patients. This consensus of experts from the Russian Medical Society for Arterial Hypertension analyzed the existing data on the relationship between COVID-19 and hypertension, the pathophysiological aspects of the penetration of the virus into target cells and the use of renin-angiotensin-aldosterone system inhibitors in patients with hypertension and COVID-19.

Keywords